Central Mechanisms of Chronic Pruritus: Functional and Structural Brain Imaging. (PRURIM)

Regional University Hospital Center (CHRU)

Status: Terminated

Conditions: Itch

Treatments: Other: MRI

Study type: Interventional

Funder types: Other

Identifiers

NCT02828787

RB 15.212 PRURIM

Details and patient eligibility

About

The main objective of this study is to identify by functional and structural MRI which are the brain areas activated in various pruritic situations to deduct a model describing the different causes of pruritus.

The investigators are going to compare two chronic pruritus conditions (histaminergic urticaria and non histaminergic: psoriasis) to a healthy control group.

The secondary objective of this study is to specify a classification index from the physiological results obtained by brain imaging to differentiate multiple types of pruritus.

Full description

Particularly invalidating in some cases, pruritus is defined as an unpleasant sensation that causes the need to scratch.

Epidemiologically, it is a common disorder as a third of the population feels in a given week. Treatment is difficult, especially as the pathophysiological mechanisms remain poorly understood, particularly in the central nervous system.

Specific pathways, or at least selective of the pruritus of transmission have been identified. From the skin to the brain, two ways exist: a histaminergic pathway (classical), and a non-histaminergic pathway (related to the activation of PAR-2 receptors by serine proteases). If urticaria belongs to the first track, the respective share of each channel is unknown to other causes of pruritus. The pruriceptors, located in the skin, transmit information by specific fibers at the spinal cord, which then project through the lateral spinothalamic tract to the thalamus. Then at midbrain and cortex, a vast network involving sensorial areas, motor and emotional areas was identified by functional neuroimaging, with activation zones which may be different depending on two channels (with overlapping zones ). The contribution to the perception of pruritus of these brain regions is the focus of current research.

A promising non-invasive method to study the pruritus channels with neuroimaging is to use the phenomenon of "contagious pruritus': seeing other people scratching, itching and sometimes scratching is induced in the observer, and the activated brain network is similar to that which is activated by pruritus usually. This phenomenon is even more important in subjects with atopic dermatitis than in healthy subjects.

In this project, the investigators plan to characterize pruritus central pathways in patients with different types of chronic pruritus compared to healthy subjects, particularly regarding the respective contributions of histaminergic pathways (pathway involved in pruritus of hives) and "PAR-2-ergic" (pathway involved in the itch of psoriasis).

Enrollment: 31 patients

Sex: All

Ages: 18+ years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Or patient affected by psoriasis presenting a pruritus of more than 6 weeks
• Or patient affected by urticaria presenting a pruritus of more than 6 weeks
• Or subject without dermatosis and not presenting chronic pruritus.
• Major
• Able to provide written informed consent
• Affiliated to the Social Security

Exclusion criteria

1. In connection with the award of an MRI namely:

   • The presence of implanted medical equipment susceptible to the magnetic field of MRI,
   • Claustrophobia
   • Medication, treatment and / or substances that could alter or modify brain function
   • Pregnancy

2. In connection with the mode of presentation of stimuli (video):

   • An uncorrected visual disorder not allowing to view videos

3. In connection with the administrative regulations:

   • Persons under 18
   • Major Persons subject to legal protection (backup justice, trusteeship, guardianship), persons deprived of liberty.

If no pruritus is induced during the first session, it will be a criterion for non inclusion for the second session.

Trial design

Primary purpose: Diagnostic

Allocation: Non-Randomized

Interventional model: Parallel Assignment

Masking: None (Open label)

---

31 participants in 3 patient groups

Urticaria

Experimental group

Description:

15 patients with urticaria

Treatment:

Other: MRI

Psoriasis

Experimental group

Description:

15 patients with psoriasis

Treatment:

Other: MRI

healthy

Other group

Description:

15 healthy control subjects

Treatment:

Other: MRI